Results 1 to 10 of about 23,719 (217)

The characteristics of upper airway edema in hereditary and acquired angioedema with C1‐inhibitor deficiency [PDF]

Clinical and Translational Allergy, 2021
Background Angioedemas localized in the upper airway are potentially life threatening, and without proper treatment, they may lead to death by suffocation. Upper airway edemas (UAE) in bradykinin‐mediated angioedemas can even be the first symptoms of the
Zsuzsanna Balla, Noémi Andrási, Zsófia Pólai, Beáta Visy, Ibolya Czaller, György Temesszentandrási, Dorottya Csuka, Lilian Varga, Henriette Farkas   +8 more
doaj   +3 more sources

Angioedemas associated with renin-angiotensin system blocking drugs: Comparative analysis of spontaneous adverse drug reaction reports. [PDF]

PLoS ONE, 2020
IntroductionAngioedema is a subcutaneous swelling typically affecting the face, larynx or pharynx. It is a known adverse drug reaction (ADR) of ACE inhibitors (ACEi), angiotensin-II-receptor blockers (ARBs) and aliskiren (renin inhibitor).
Diana Dubrall, Matthias Schmid, Julia Carolin Stingl, Bernhardt Sachs   +3 more
doaj   +3 more sources

Over diagnosis of bradykinin angioedema in patients treated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers [PDF]

World Allergy Organization Journal, 2023
Background: Bradykinin angioedemas are a potentially serious side effect of angiotensin-converting enzyme inhibitors (ACEI) and more controversially of angiotensin II receptor blockers (ARB).
Marie Douillard, MD, Zineb Deheb, MD, Agathe Bozon, MD, Nadia Raison-Peyron, MD, Olivier Dereure, MD, PhD, Lionel Moulis, MD, Angèle Soria, MD, PhD, Aurélie Du-Thanh, MD, PhD   +7 more
doaj   +2 more sources

Screening for Plasminogen Mutations in Hereditary Angioedema Patients. [PDF]

Genes (Basel), 2021
Hereditary angioedema (HAE) is a rare disease belonging to the group of bradykinin-mediated angioedemas, characterized by recurring edematous episodes involving the subcutaneous and/or submucosal tissues.
Farkas H, Dóczy A, Szabó E, Varga L, Csuka D.   +4 more
europepmc   +2 more sources

Pathophysiology of bradykinin and histamine mediated angioedema. [PDF]

Front Allergy, 2023
Angioedema is characterized by swelling localized to the subcutaneous and submucosal tissues. This review provides an overview of angioedema, including the different types, triggers, and underlying pathophysiologic mechanisms.
Lima H, Zheng J, Wong D, Waserman S, Sussman GL.   +4 more
europepmc   +2 more sources

Hereditary angioedema prevalence and satisfaction with prophylaxis in South Australia [PDF]

World Allergy Organization Journal
Background: Hereditary angioedema (HAE) due to deficiency of C1 Inhibitor (C1INH-HAE) is a rare, unpredictable and potentially fatal genetic disorder. There are relatively few systematic population prevalence studies, with reports from various countries ...
Alexander Troelnikov, MBBS, Karen Milburn, RN, Pravin Hissaria, MBBS, MD, Thanh Thao (Adriana) Le, MBBS, William Smith, MBBS, PhD   +4 more
doaj   +2 more sources

A case of angioedema of hereditary origin in a rural clinic near Subotica [PDF]

ABC: časopis urgentne medicine, 2023
Introduction: Hereditary angioedema (HAE) is inherited in an autosomal dominant manner. It manifests with bradykinin-mediated swelling due to a deficiency of C1 inhibitor.
Gavrilović Nikola, Momirović-Stojković Milena, Budimski-Soldat Mihaela   +2 more
doaj   +1 more source

Long-term prophylaxis of hereditary angioedema [PDF]

Liječnički vjesnik, 2022
Hereditary angioedema (HAE) is a rare inherited disease characterized by recurrent attacks of painful swelling of the subcutaneous and submucosal tissues.
Dijana Perković, Marko Barešić, Melanija Ražov Radas, Irena Jureković, Srđan Novak, Branimir Anić, jerka Karadža Lapić, Višnja Prus, Asja Stipić Marković   +8 more
doaj   +1 more source

Assessment of HAE prophylaxis transition from androgen therapy to berotralstat: A subset analysis of the APeX-S trial

World Allergy Organization Journal, 2023
Background: Given the recent approval of oral berotralstat in several countries for hereditary angioedema (HAE) prophylaxis, transition from long-term androgens to berotralstat may occur in clinical practice.
Jonny G. Peter, MB ChB, MMed, FCP (SA), PhD, Bhavisha Desai, PharmD, Dianne Tomita, MPH, Phil Collis, PhD, Marcin Stobiecki, MD, PhD   +4 more
doaj   +1 more source

The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

Allergy. European Journal of Allergy and Clinical Immunology, 2021
This update and revision of the international guideline for urticaria was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. It is a joint initiative of
T. Zuberbier, A. A. Abdul Latiff, M. Abuzakouk, S. Aquilina, R. Asero, D. Baker, B. Ballmer-Weber, C. Bangert, M. Ben-Shoshan, J. Bernstein, C. Bindslev‐Jensen, K. Brockow, Z. Brzoza, H. C. Chong Neto, M. Church, P. Criado, I. Danilycheva, C. Dressler, L. Ensina, L. Fonacier, M. Gaskins, K. Gáspár, A. Gelincik, A. Giménez-Arnau, K. Godse, M. Gonçalo, C. Grattan, M. Grosber, E. Hamelmann, J. Hébert, M. Hide, A. Kaplan, A. Kapp, A. Kessel, Emek Kocatürk, K. Kulthanan, D. Larenas-Linnemann, A. Lauerma, T. Leslie, M. Magerl, M. Makris, R. Meshkova, M. Metz, D. Micallef, C. Mortz, A. Nast, H. Oude-Elberink, R. Pawankar, P. Pigatto, H. Ratti Sisa, M. I. Rojo Gutiérrez, S. Saini, P. Schmid‐Grendelmeier, B. Sekerel, F. Siebenhaar, H. Siiskonen, A. Soria, P. Staubach‐Renz, L. Stingeni, G. Sussman, A. Szegedi, S. Thomsen, Z. Vadasz, C. Vestergaard, B. Wedi, Zuotao Zhao, M. Maurer   +66 more
semanticscholar   +1 more source